Newswise — Chicago IL: Top residents, fellows, and students who specialize in hematology/oncology pharmacy were recognized at the recent Hematology/Oncology Pharmacy Association (HOPA) Annual Conference this past March for their Trainee Research in Progress submissions. The HOPA Annual Conference gives hematology/oncology pharmacy professionals the opportunity to present their work in poster form within an atmosphere of support by peers and national leaders. Applicants submitted their original research projects in two categories - Clinical/Translations Research and Practice Management. Encore presentations from a previous meeting were also allowed. From a pool of 145 Trainee Research in Progress poster submissions, 10 finalists were selected. The winner was selected based on a rigorous in-person review and evaluation.
First Place
Ryan Caddell, PharmDDepartment of Pharmacy, West Virginia University Healthcare - Ruby Memorial HospitalEvaluation of Posaconazole Serum Concentrations in Hematological Malignancy Patients Receiving Tablets Compared to the Suspension Formulation
Finalists
Christine Cambareri, PharmD BCPSDepartment of Pharmacy, Yale New Haven Health SystemThe Use of Oral Anticoagulants for the Treatment of Venous Thromboembolism in Cancer Patients
Abraham ChangDepartment of Pharmacy, Stanford Health CareHypersensitivity Reactions Associated with Pegaspargase in Adults
Tina Melancon, PharmDDepartment of Pharmacy, The University of Kansas HospitalComparison of Postoperative Venous Thromboembolism Incidence in Gastrointestinal and Gynecologic Solid Tumors
Khilna Patel, PharmDDepartment of Pharmacy, New York Presbyterian HospitalComparison of Subcutaneous versus Intravenous Alemtuzumab for GVHD Prophylaxis with Fludarabine/Melphalan Based Conditioning in Allogeneic Stem Cell Transplant
Courtney Porter, PharmDDepartment of Pharmacy, The University of Kansas HospitalPrognostic Marker Discordance between Breast and Axilla in Patients with Early Breast Cancer
Marisela Tan, PharmD BCPSDepartment of Clinical Pharmacy, University of California, San Francisco Medical CenterRetrospective Review of Pertuzumab, Trastuzumab, Taxane Combination versus Ado-Trastuzumab Emtansine Monotherapy in Trastuzumab-Experienced HER2+ Advanced Breast Cancer
Sarah Hogue, PharmDDepartment of Pharmacy, St. Luke's Mountain States Tumor InstituteEvaluation of Dosing Differences in Oncology Clinical Research Trials and the Impact of a Dosing Worksheet on Protocol Compliance
Britny Rogala, PharmDDepartment of Pharmacy, Roswell Park Cancer InstituteOral Chemotherapy: Pharmacist Impact on Adherence, Patient Safety, and Quality Indicators
Hilary ThomasDepartment of Pharmacy, University of Cincinnati Medical CenterPharmacy Driven Process Improvement Initiative for Time to Antibiotic Administration in Febrile Neutropenia
###
HOPA is a nonprofit professional organization formed in 2004 to help oncology and hematology pharmacy practitioners and their associates provide the best possible cancer care. HOPA supports research, conducts educational conferences to advance knowledge, encourages professional development and advocates for health policy issues that improve patient care. HOPA has more than 2300 members and includes oncology pharmacists, as well as pharmacy interns, residents, nurses, technicians, researchers, and administrators specializing in hematology/oncology practice. To learn more about HOPA, visit www.hoparx.org.
RSS